BRAINSTORM CELL THERAPEUTICS INC·4

Feb 19, 5:14 PM ET

STOLICK DAVID 4

4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Feb 19, 2010

Insider Transaction Report

Form 4
Period: 2010-02-12
STOLICK DAVID
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2010-02-12$0.36/sh5,000$1,800395,000 total
  • Sale

    Common Stock

    2010-02-16$0.36/sh3,000$1,080392,000 total
  • Sale

    Common Stock

    2010-02-16$0.36/sh140,000$50,400252,000 total
  • Sale

    Common Stock

    2010-02-17$0.36/sh2,000$720250,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2010-02-12+400,0000 total
    Exercise: $0.15Exp: 2015-02-13Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]The option is fully vested and exercisable

Documents

1 file
  • 4
    v175059_ex.xmlPrimary